Morepen Laboratories has informed that it enclosed press release with the title ‘Morepen to Launch Resmetirom - a New Drug for Fatty Liver’. The disclosures as required under the SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, form part of the aforesaid press release.
The above information is a part of company’s filings submitted to BSE.